Repatha is the FIRST PCSK9 approved in Canada! Important news for all families with FH and uncontrolled LDL cholesterol at risk for cardiovascular disease.
HEALTH CANADA APPOVES AMGEN’S NEW CHOLESTEROL-LOWERING MEDICATION REPATHA (EVOLOCUMAB)
Repatha Reduced LDL-C by up to 75 Per Cent Compared with Placebo.
First in a New Class of Cholesterol-Lowering Drugs Offers Canadian Physicians and Patients a New Choice Cholesterol Management
Please read full news release below for more information on Repatha approval.
Repatha NOC News Release ENGLISH
Repatha NOC News Release FRENCH
Please note: This information is for Canada Media Only